Is pharmaceutical policy evidence-informed? A case of the deregulation process of nicotine replacement therapy products in Finland

Terhi Kurko, Antti Silvast, Hannes Wahlroos, Kirsi Pietilä and Marja Airaksinen

Health Policy, 2012, vol. 105, issue 2, 246-255

Abstract: This qualitative study aims to identify the key dimensions of the political argumentation in the debate leading up to the deregulation of nicotine replacement therapy products (NRT) in Finland in 2006. The deregulation was introduced by the Amendment of larger package of changes in medical legislation prepared in 2005.

Keywords: Evidence informed decision-making; Pharmaceutical policy; Nicotine replacement therapy; Deregulation; Qualitative research (search for similar items in EconPapers)
Date: 2012
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851012000401
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:105:y:2012:i:2:p:246-255

DOI: 10.1016/j.healthpol.2012.02.013

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().